These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 13052966)

  • 21. Humoral and cell-mediated immunity to the intracellular pathogen Francisella tularensis.
    Kirimanjeswara GS; Olmos S; Bakshi CS; Metzger DW
    Immunol Rev; 2008 Oct; 225():244-55. PubMed ID: 18837786
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Studies on the pathogenesis of tularemia. III. Survival of B. tularense in the organism of normal and immunized rabbits].
    SKRODZKI E
    Biul Inst Med Morsk Gdansk; 1961; 12():45-50. PubMed ID: 13913724
    [No Abstract]   [Full Text] [Related]  

  • 23. [Tularemia, "volume" two].
    Macela A
    Epidemiol Mikrobiol Imunol; 1998 Aug; 47(3):103-20. PubMed ID: 9748768
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Studies on protection against experimental tularemia in mice. II. Immunogenicity of Bacterium tularense filtrates in mice and enhancement by Hemophilus pertussis vaccine.
    PANNELL L
    J Infect Dis; 1958; 102(2):167-73. PubMed ID: 13525776
    [No Abstract]   [Full Text] [Related]  

  • 25. Oral immunization of mice with the live vaccine strain (LVS) of Francisella tularensis protects mice against respiratory challenge with virulent type A F. tularensis.
    KuoLee R; Harris G; Conlan JW; Chen W
    Vaccine; 2007 May; 25(19):3781-91. PubMed ID: 17346863
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tacrine alters antibodies level in Francisella tularensis-infected mice.
    Pohanka M; Pavlis O; Pikula J
    Neuro Endocrinol Lett; 2013; 34 Suppl 2():134-7. PubMed ID: 24362106
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Study of the immunizing effect of the virulent Tularemia strain treated by streptomycin].
    Brikman DI
    Antibiotiki; 1971 Sep; 16(9):827-31. PubMed ID: 5139456
    [No Abstract]   [Full Text] [Related]  

  • 28. Progress, challenges, and opportunities in Francisella vaccine development.
    Elkins KL; Kurtz SL; De Pascalis R
    Expert Rev Vaccines; 2016 Sep; 15(9):1183-96. PubMed ID: 27010448
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lipoxin A4, a 5-lipoxygenase pathway metabolite, modulates immune response during acute respiratory tularemia.
    Singh A; Rahman T; Bartiss R; Arabshahi A; Prasain J; Barnes S; Musteata FM; Sellati TJ
    J Leukoc Biol; 2017 Feb; 101(2):531-542. PubMed ID: 27630217
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Dynamics of antibodies against tularemia following immunization with a live tularemia vaccine].
    Richter J; Vítková V; Stehlík J; Minaríková H
    Cesk Epidemiol Mikrobiol Imunol; 1965 Jul; 14(4):221-4. PubMed ID: 4220875
    [No Abstract]   [Full Text] [Related]  

  • 31. Host resistance to the LVS strain of Francisella tularensis in BCG vaccinated mice.
    Taplits MS; Myrvik QN
    J Reticuloendothel Soc; 1977 Oct; 22(4):297-308. PubMed ID: 411926
    [No Abstract]   [Full Text] [Related]  

  • 32. [Comparative evaluation of the effectiveness of various methods of determining the immunity in those inoculated against tularemia].
    Timoshenko VI
    Zh Mikrobiol Epidemiol Immunobiol; 1979 Oct; (10):113. PubMed ID: 388950
    [No Abstract]   [Full Text] [Related]  

  • 33. [Study of the mechanism of action of antibiotics on the development of immunity in experimental tularemia].
    Tsareva SA
    Antibiotiki; 1967 Aug; 12(8):704-8. PubMed ID: 5588646
    [No Abstract]   [Full Text] [Related]  

  • 34. Intranasal vaccination with a defined attenuated Francisella novicida strain induces gamma interferon-dependent antibody-mediated protection against tularemia.
    Pammit MA; Raulie EK; Lauriano CM; Klose KE; Arulanandam BP
    Infect Immun; 2006 Apr; 74(4):2063-71. PubMed ID: 16552035
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Time course of the production of immunoglobulins in patients with tularemia].
    Ohara S; Sato T; Homma M
    Nihon Saikingaku Zasshi; 1984 Mar; 39(2):103-6. PubMed ID: 6748218
    [No Abstract]   [Full Text] [Related]  

  • 36. Studies on pathogenesis and immunity in tularemia; the pathogenesis of tularemia in the white rat.
    DOWNS CM; BUCHELE L; EDGAR EP
    J Immunol; 1949 Oct; 63(2):117-33. PubMed ID: 15390502
    [No Abstract]   [Full Text] [Related]  

  • 37. Protection of vaccinated mice against pneumonic tularemia is associated with an early memory sentinel-response in the lung.
    Bar-On L; Cohen H; Elia U; Rotem S; Bercovich-Kinori A; Bar-Haim E; Chitlaru T; Cohen O
    Vaccine; 2017 Dec; 35(50):7001-7009. PubMed ID: 29102170
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Tularemia vaccine strain is a potential vector].
    Pavlov VM; Mokrievich AN; Noskov AN; Urakov NN
    Vestn Ross Akad Med Nauk; 1997; (6):30-2. PubMed ID: 9289276
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Further studies on protective filtrates of Pasteurella tularensis broth cultures.
    PANNELL L; CORDLE MS
    J Infect Dis; 1962; 111():49-54. PubMed ID: 14483554
    [No Abstract]   [Full Text] [Related]  

  • 40. [Simultaneous vaccination by the epicutaneous method against plague, brucellosis and tularemia].
    UZBEKOVA BR; SHMUTER MF; ABDULLINA GA
    Zdravookhranenie Kazakhstana; 1962; 22(7)():63-8. PubMed ID: 13924058
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.